SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-025050
Filing Date
2022-11-14
Accepted
2022-11-14 17:17:49
Documents
14
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K harp-20221114.htm   iXBRL 8-K 65757
2 EX-99.1 harp-ex99_1.htm EX-99.1 257940
3 GRAPHIC img80376846_0.jpg GRAPHIC 4909
  Complete submission text file 0000950170-22-025050.txt   466952

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT harp-20221114_pre.xml EX-101.PRE 11369
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT harp-20221114.xsd EX-101.SCH 2467
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT harp-20221114_lab.xml EX-101.LAB 13896
8 EXTRACTED XBRL INSTANCE DOCUMENT harp-20221114_htm.xml XML 4903
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 221387700
SIC: 2836 Biological Products, (No Diagnostic Substances)